2023 Q4 Form 10-Q Financial Statement

#000143462123000022 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $134.4M $155.2M
YoY Change -33.51% -34.75%
Cost Of Revenue $8.126M $7.570M
YoY Change -39.94% -46.33%
Gross Profit $126.2M $69.07M
YoY Change -33.05% -25.14%
Gross Profit Margin 93.95% 44.51%
Selling, General & Admin $108.6M $123.6M
YoY Change -37.29% -42.88%
% of Gross Profit 86.07% 178.99%
Research & Development $11.10M $10.84M
YoY Change -15.52% -22.81%
% of Gross Profit 8.79% 15.69%
Depreciation & Amortization $6.513M $4.760M
YoY Change -26.01% -9.75%
% of Gross Profit 5.16% 6.89%
Operating Expenses $126.3M $134.5M
YoY Change -35.31% -41.65%
Operating Profit -$32.00K -$33.99M
YoY Change -99.52% 82.99%
Interest Expense $10.69M -$7.097M
YoY Change -277.51% 24.07%
% of Operating Profit
Other Income/Expense, Net $2.644M -$110.9M
YoY Change 29.8% -7382.34%
Pretax Income $13.12M -$152.0M
YoY Change -215.67% 567.45%
Income Tax $397.0K -$3.534M
% Of Pretax Income 3.03%
Net Earnings $12.72M -$148.5M
YoY Change -222.25% -6.44%
Net Earnings / Revenue 9.47% -95.67%
Basic Earnings Per Share -$11.43
Diluted Earnings Per Share $0.98 -$11.43
COMMON SHARES
Basic Shares Outstanding 13.00M shares 12.97M shares
Diluted Shares Outstanding 12.99M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.1M $175.6M
YoY Change -62.51% -38.51%
Cash & Equivalents $112.1M $175.6M
Short-Term Investments
Other Short-Term Assets $29.48M $13.26M
YoY Change -8.07% -53.62%
Inventory
Prepaid Expenses
Receivables $54.95M $64.33M
Other Receivables $0.00 $0.00
Total Short-Term Assets $196.5M $266.9M
YoY Change -52.54% -34.98%
LONG-TERM ASSETS
Property, Plant & Equipment $50.48M $54.20M
YoY Change -14.67% -16.42%
Goodwill $381.5M $381.5M
YoY Change -9.19% -9.19%
Intangibles $50.62M $52.30M
YoY Change -13.2% -18.52%
Long-Term Investments $60.08M $60.08M
YoY Change -65.59% -65.59%
Other Assets $6.339M $6.426M
YoY Change 3.9% 1.87%
Total Long-Term Assets $606.3M $618.1M
YoY Change -22.8% -22.72%
TOTAL ASSETS
Total Short-Term Assets $196.5M $266.9M
Total Long-Term Assets $606.3M $618.1M
Total Assets $802.8M $885.0M
YoY Change -33.07% -26.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.960M $1.560M
YoY Change -3.45% -65.96%
Accrued Expenses $70.54M $66.99M
YoY Change -6.06% -20.69%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.125M $2.500M
YoY Change 25.0% 0.64%
Total Short-Term Liabilities $75.63M $71.05M
YoY Change -8.37% -22.38%
LONG-TERM LIABILITIES
Long-Term Debt $525.6M $625.7M
YoY Change -35.39% -23.07%
Other Long-Term Liabilities $267.0K $253.0K
YoY Change -13.31% -9.96%
Total Long-Term Liabilities $525.9M $626.0M
YoY Change -35.38% -23.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $75.63M $71.05M
Total Long-Term Liabilities $525.9M $626.0M
Total Liabilities $678.6M $782.4M
YoY Change -31.55% -22.06%
SHAREHOLDERS EQUITY
Retained Earnings -$837.7M -$850.4M
YoY Change 17.11% 20.65%
Common Stock $1.228B $1.219B
YoY Change 3.25% 3.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $266.2M $266.2M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $124.1M $102.6M
YoY Change
Total Liabilities & Shareholders Equity $802.8M $885.0M
YoY Change -33.07% -26.88%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $12.72M -$148.5M
YoY Change -222.25% -6.44%
Depreciation, Depletion And Amortization $6.513M $4.760M
YoY Change -26.01% -9.75%
Cash From Operating Activities $20.88M $18.47M
YoY Change 25.44% 80.55%
INVESTING ACTIVITIES
Capital Expenditures $2.600M $5.075M
YoY Change 5.14% -293.41%
Acquisitions
YoY Change
Other Investing Activities $50.00K $0.00
YoY Change 614.29%
Cash From Investing Activities -$2.550M -$5.075M
YoY Change 3.41% 93.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -81.86M -485.0K
YoY Change 9254.97% -58.65%
NET CHANGE
Cash From Operating Activities 20.88M 18.47M
Cash From Investing Activities -2.550M -5.075M
Cash From Financing Activities -81.86M -485.0K
Net Change In Cash -63.53M 12.91M
YoY Change -577.5% 100.68%
FREE CASH FLOW
Cash From Operating Activities $20.88M $18.47M
Capital Expenditures $2.600M $5.075M
Free Cash Flow $18.28M $13.39M
YoY Change 28.98% 4.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Revenues
Revenues
155188000 usd
CY2022Q3 us-gaap Revenues
Revenues
237836000 usd
us-gaap Revenues
Revenues
538149000 usd
us-gaap Revenues
Revenues
782937000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
7570000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
14105000 usd
us-gaap Cost Of Revenue
CostOfRevenue
30632000 usd
us-gaap Cost Of Revenue
CostOfRevenue
44240000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
97244000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
350420000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
565569000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26380000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39540000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92223000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115808000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10840000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6582000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6012000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21574000 usd
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176875000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14043000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36096000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42413000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4760000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5274000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14239000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15024000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1981000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
38600000 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
38600000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
1955000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
9967000 usd
us-gaap Restructuring Charges
RestructuringCharges
3760000 usd
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
150000 usd
CY2022Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-350000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
41000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
189180000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
256412000 usd
us-gaap Costs And Expenses
CostsAndExpenses
578539000 usd
us-gaap Costs And Expenses
CostsAndExpenses
808347000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-33992000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18576000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-40390000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25410000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7097000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5720000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10992000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19990000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-110910000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1523000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-108637000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1806000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151999000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22773000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138035000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43594000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3534000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135911000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2912000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133954000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-148465000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-148465000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-158684000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-158684000 usd
us-gaap Net Income Loss
NetIncomeLoss
-135123000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-135123000 usd
us-gaap Net Income Loss
NetIncomeLoss
-177548000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-177548000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12993000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12758000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12919000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12794000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12993000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12758000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12919000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12794000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.43
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.88
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.43
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.88
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175580000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298845000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
124000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2449000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2317000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64334000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83060000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26959000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26250000 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5689000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
266876000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
413968000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37116000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33851000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54199000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59160000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63565000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
67050000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
381539000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
420139000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
52302000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58315000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
60076000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
174580000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6426000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6101000 usd
CY2023Q3 us-gaap Assets
Assets
884983000 usd
CY2022Q4 us-gaap Assets
Assets
1199313000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2500000 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1560000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2030000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66986000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75095000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2909000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
71046000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
82534000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
625749000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
813516000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
82822000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88232000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2494000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6783000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
253000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
308000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
782364000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
991373000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16357312 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16167184 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13001846 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12811718 shares
CY2023Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
164000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
162000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1219055000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1189255000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-850422000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715299000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3355466 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3355466 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
266178000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
266178000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
207940000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
884983000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1199313000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
207940000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13457000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11274000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1693000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
230979000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-115000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10199000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
652000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
241715000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-148465000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-148465000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9854000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-485000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
447992000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10826000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10826000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15080000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
43009000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3086000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
340848000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8038000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-8038000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17335000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
341000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
350486000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-158684000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-158684000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15575000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-880000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
206497000 usd
us-gaap Net Income Loss
NetIncomeLoss
-135123000 usd
us-gaap Net Income Loss
NetIncomeLoss
-177548000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5255000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4261000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6012000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21574000 usd
us-gaap Depreciation
Depreciation
14239000 usd
us-gaap Depreciation
Depreciation
15024000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
31327000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
47990000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4289000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
133943000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1803000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2708000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3473000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5443000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2373000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1475000 usd
tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-3118000 usd
tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-890000 usd
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
34308000 usd
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
114504000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
38600000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18276000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1380000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
525000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6271000 usd
tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-11878000 usd
tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-19149000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
1115000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-389000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1044000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
469000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46692000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26322000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9928000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8970000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16440000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9928000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25410000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
250000000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1250000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
625000 usd
tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-1527000 usd
tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-3292000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
43009000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1079000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-160150000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33411000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-123386000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34323000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175583000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
285665000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the impact of the current economic conditions, including interest rates and inflation on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional information is obtained. If </span></div>economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Risks and Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and credit card fraud.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk at September 30, 2023, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which, in the event of non-payment, would be applied against any accounts receivable outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.</span></div>
CY2023Q3 us-gaap Revenues
Revenues
155188000 usd
CY2022Q3 us-gaap Revenues
Revenues
237836000 usd
us-gaap Revenues
Revenues
538149000 usd
us-gaap Revenues
Revenues
782937000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13700000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12200000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
900000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 usd
CY2023Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-100000 usd
CY2022Q3 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
100000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175580000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
298845000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
124000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175583000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298969000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2609000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-91000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
679000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1803000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2708000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
102000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
623000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2075000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1808000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
33000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
33000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2023Q3 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
CY2022Q3 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
371000 usd
tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2449000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2356000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2449000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2356000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42160000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4200000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2100000 usd
CY2023Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
1700000 usd
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
400000 usd
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
521688000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
483088000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
381539000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
420139000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48173000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
52302000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58315000 usd
CY2023Q3 us-gaap Share Price
SharePrice
15.50
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
86400000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44240000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42160000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
87400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39227000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48173000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1682000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5889000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5830000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5504000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5198000 usd
CY2023Q3 tree Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
18057000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
113100000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
1400000 usd
CY2022 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q3 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
27696000 usd
CY2022Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
37703000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10693000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11444000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1014000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1393000 usd
CY2023Q3 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7282000 usd
CY2022Q4 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7273000 usd
CY2023Q3 tree Charitable Contribution Accrual
CharitableContributionAccrual
0 usd
CY2022Q4 tree Charitable Contribution Accrual
CharitableContributionAccrual
500000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8442000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8513000 usd
CY2023Q3 tree Accrued Restructuring And Severance Current
AccruedRestructuringAndSeveranceCurrent
2002000 usd
CY2022Q4 tree Accrued Restructuring And Severance Current
AccruedRestructuringAndSeveranceCurrent
304000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9857000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7965000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66986000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75095000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12993000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12758000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12919000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12794000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2022Q3 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12993000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12758000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12919000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12794000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
379895 shares
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
96700000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9854000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15575000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31327000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47990000 usd
CY2023Q3 us-gaap Share Price
SharePrice
15.50
CY2023Q3 us-gaap Share Price
SharePrice
15.50
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3534000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135911000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2912000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133954000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.023
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-5.968
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.021
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-3.073
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
139700000 usd
CY2022Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
139700000 usd
CY2022Q3 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
1800000 usd
tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
4700000 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q3 tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-3534000 usd
CY2022Q3 tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-5511000 usd
tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-2912000 usd
tree Income Tax Benefit Expense Excluding Excess Tax Expense Benefit On Stock Compensation
IncomeTaxBenefitExpenseExcludingExcessTaxExpenseBenefitOnStockCompensation
-10374000 usd
CY2023Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 usd
CY2022Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
139670000 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
139670000 usd
CY2023Q3 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
0 usd
CY2022Q3 tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
1752000 usd
tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
0 usd
tree Excess Tax Expense Benefit On Stock Compensation Income Tax Expense Benefit
ExcessTaxExpenseBenefitOnStockCompensationIncomeTaxExpenseBenefit
4658000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3534000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
135911000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2912000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133954000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2023Q3 us-gaap Litigation Reserve
LitigationReserve
600000 usd
CY2022Q4 us-gaap Litigation Reserve
LitigationReserve
100000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2023Q3 us-gaap Revenues
Revenues
155188000 usd
CY2023Q3 us-gaap Marketing Expense
MarketingExpense
86119000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
69069000 usd
CY2023Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
7570000 usd
CY2023Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
11125000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26380000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10840000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4760000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1981000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
38600000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
1955000 usd
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
150000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-33992000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7097000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-110910000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151999000 usd
CY2022Q3 us-gaap Revenues
Revenues
237836000 usd
CY2022Q3 us-gaap Marketing Expense
MarketingExpense
145569000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
92267000 usd
CY2022Q3 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
14105000 usd
CY2022Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
31306000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39540000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14043000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5274000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6582000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
7000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18576000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5720000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1523000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22773000 usd
us-gaap Revenues
Revenues
538149000 usd
us-gaap Marketing Expense
MarketingExpense
310614000 usd
us-gaap Gross Profit
GrossProfit
227535000 usd
us-gaap Cost Of Revenue
CostOfRevenue
30632000 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
39806000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92223000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36096000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14239000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6012000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
38600000 usd
us-gaap Restructuring Charges
RestructuringCharges
9967000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-350000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-40390000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10992000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-108637000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138035000 usd
us-gaap Revenues
Revenues
782937000 usd
us-gaap Marketing Expense
MarketingExpense
497441000 usd
us-gaap Gross Profit
GrossProfit
285496000 usd
us-gaap Cost Of Revenue
CostOfRevenue
44240000 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
68128000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115808000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42413000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15024000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21574000 usd
us-gaap Restructuring Charges
RestructuringCharges
3760000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
41000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-25410000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-19990000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1806000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43594000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001434621-23-000022-index-headers.html Edgar Link pending
0001434621-23-000022-index.html Edgar Link pending
0001434621-23-000022.txt Edgar Link pending
0001434621-23-000022-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tree-20230930.htm Edgar Link pending
tree-20230930.xsd Edgar Link pending
tree-20230930_g1.jpg Edgar Link pending
tree-20230930_g2.jpg Edgar Link pending
tree-20230930_cal.xml Edgar Link unprocessable
tree-20230930_lab.xml Edgar Link unprocessable
tree-20230930_htm.xml Edgar Link completed
tree-2023930x10qexx311.htm Edgar Link pending
tree-2023930x10qexx312.htm Edgar Link pending
tree-2023930x10qexx321.htm Edgar Link pending
tree-2023930x10qexx322.htm Edgar Link pending
tree-20230930_def.xml Edgar Link unprocessable
tree-20230930_pre.xml Edgar Link unprocessable